Annual Report

Overview

The report describes how the COVID-19 pandemic disrupted pharmaceutical markets and operations, while Renata maintained product availability, implemented hygiene and distancing protocols, and supported affected communities. The consolidated group reported turnover of Taka 24,674,812,094 for 2019-2020. The report also records a workforce of 8,151 employees and extensive CSR support, including healthcare, scholarships, charitable donations and pandemic relief.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019-2020
Period: 1 July 2019 – 30 June 2020
Publication date: 26 October 2020
Language: English
Pages
File size

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services